Profilo
Mr. Roy M.
Gonzales was previously employed as a Chief Financial & Accounting Officer by Ventyx Biosciences, Inc., a Vice President-Finance by Landos Biopharma, Inc., and a Vice President-Finance & SEC Reporting by Histogen, Inc. He received his undergraduate degree from Old Dominion University, an undergraduate degree from Virginia Polytechnic Institute & State University and an MBA from the University of California, Los Angeles.
Precedenti posizioni note di Roy Gonzales
| Società | Posizione | Fine |
|---|---|---|
| VENTYX BIOSCIENCES, INC. | Direttore Finanziario/CFO | 04/03/2026 |
| LANDOS BIOPHARMA, INC. | Corporate Officer/Principal | 01/06/2022 |
| HISTOGEN INC. | Corporate Officer/Principal | 01/09/2021 |
Formazione di Roy Gonzales
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Old Dominion University
Old Dominion University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Virginia Polytechnic Institute & State University
Virginia Polytechnic Institute & State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Landos Biopharma, Inc.
Landos Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases | Health Technology |
Histogen, Inc.
Histogen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage therapeutics company that develops potential clinical and preclinical drugs | Health Technology |
Ventyx Biosciences, Inc.
Ventyx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapies for patients with autoimmune, inflammatory and neurodegenerative diseases | Health Technology |
















